Literature DB >> 33289470

A Tale of Two Viruses: Coinfections of Monkeypox and Varicella Zoster Virus in the Democratic Republic of Congo.

Christine M Hughes1, Lindy Liu2,3, Whitni B Davidson1, Kay W Radford4, Kimberly Wilkins1, Benjamin Monroe1, Maureen G Metcalfe3, Toutou Likafi5, Robert Shongo Lushima6, Joelle Kabamba7, Beatrice Nguete5, Jean Malekani8, Elisabeth Pukuta9, Stomy Karhemere9, Jean-Jacques Muyembe Tamfum9, Emile Okitolonda Wemakoy5, Mary G Reynolds1, D Scott Schmid4, Andrea M McCollum1.   

Abstract

Recent enhanced monkeypox (MPX) surveillance in the Democratic Republic of Congo, where MPX is endemic, has uncovered multiple cases of MPX and varicella zoster virus (VZV) coinfections. The purpose of this study was to verify if coinfections occur and to characterize the clinical nature of these cases. Clinical, epidemiological, and laboratory results were used to investigate MPX/VZV coinfections. A coinfection was defined as a patient with at least one Orthopoxvirus/MPX-positive sample and at least one VZV-positive sample within the same disease event. Between September 2009 and April 2014, 134 of the 1,107 (12.1%) suspected MPX cases were confirmed as MPX/VZV coinfections. Coinfections were more likely to report symptoms than VZV-alone cases and less likely than MPX-alone cases. Significantly higher lesion counts were observed for coinfection cases than for VZV-alone but less than MPX-alone cases. Discernible differences in symptom and rash severity were detected for coinfection cases compared with those with MPX or VZV alone. Findings indicate infection with both MPX and VZV could modulate infection severity. Collection of multiple lesion samples allows for the opportunity to detect coinfections. As this program continues, it will be important to continue these procedures to assess variations in the proportion of coinfected cases over time.

Entities:  

Mesh:

Year:  2020        PMID: 33289470      PMCID: PMC7866336          DOI: 10.4269/ajtmh.20-0589

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   3.707


  8 in total

1.  [Diagnosis and treatment of human monkeypox].

Authors:  Kai-Hu Yao; Qian-Qian DU; Ya-Hong Hu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022 Sept 15

Review 2.  Monkeypox virus from neurological complications to neuroinvasive properties: current status and future perspectives.

Authors:  Ali Sepehrinezhad; Rezan Ashayeri Ahmadabad; Sajad Sahab-Negah
Journal:  J Neurol       Date:  2022-08-21       Impact factor: 6.682

3.  Monkeypox in pregnancy: virology, clinical presentation, and obstetric management.

Authors:  Pradip Dashraath; Karin Nielsen-Saines; Anne Rimoin; Citra N Z Mattar; Alice Panchaud; David Baud
Journal:  Am J Obstet Gynecol       Date:  2022-08-17       Impact factor: 10.693

4.  Monkeypox Clinical Features and Differential Diagnosis: First Case in Campania Region.

Authors:  Novella Carannante; Claudia Tiberio; Raffaele Bellopede; Michela Liguori; Filomena Di Martino; Nicola Maturo; Raffaele Di Sarno; Sabrina Scarica; Giovanna Fusco; Lorena Cardillo; Claudio de Martinis; Luigi Atripaldi; Alessandro Perrella
Journal:  Pathogens       Date:  2022-08-01

Review 5.  New challenges in human monkeypox outside Africa: A review and case report from Italy.

Authors:  Davide Mileto; Agostino Riva; Miriam Cutrera; Davide Moschese; Alessandro Mancon; Luca Meroni; Andrea Giacomelli; Giovanna Bestetti; Giuliano Rizzardini; Maria Rita Gismondo; Spinello Antinori
Journal:  Travel Med Infect Dis       Date:  2022-06-20       Impact factor: 20.441

Review 6.  Monkeypox: A clinical update for paediatricians.

Authors:  Yuanfei A Huang; Annaleise R Howard-Jones; Shireen Durrani; Zhicheng Wang; Phoebe Cm Williams
Journal:  J Paediatr Child Health       Date:  2022-08-18       Impact factor: 1.929

7.  The diversity of clinical manifestations of human monkeypox should be emphasized in practice.

Authors:  Kaihu Yao
Journal:  Pediatr Investig       Date:  2022-09-22

8.  Environmental Persistence of Monkeypox Virus on Surfaces in Household of Person with Travel-Associated Infection, Dallas, Texas, USA, 2021.

Authors:  Clint N Morgan; Florence Whitehill; Jeffrey B Doty; Joann Schulte; Audrey Matheny; Joey Stringer; Lisa J Delaney; Richard Esparza; Agam K Rao; Andrea M McCollum
Journal:  Emerg Infect Dis       Date:  2022-08-11       Impact factor: 16.126

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.